NEWS

DCB angioplasty for MCA stenosis

Foramen magnum dural AVF

Cerenovus launches largest global registry to study stroke-inducing bloo...

Company Also Receives European CE Mark Approval for Novel Stroke Technology Designed for Difficult to Extract Blood ClotsIRVINE, Calif., Dec. 10, 2018 -- Johnson & Johnson Medical Devices Companies* today announced that its CERENOVUS business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyze stroke-inducing blood clots removed from the brain with its EMBOTRAP II Revascularization Device, a next generation stent retriever used in mechanical thrombectomy.

Pediatric giant basilar top aneursym

3rd regional course in diag. and treatment of ICH

Don't miss the best of LINNC Asia 2018

AVM treated with PHIL

Chasing sunshine at LINNC Americas Miami 2019!

Bi-lobulated ACA aneurysm simulation treatment

World Stroke Day -- SVIN latest clinical trials and breaking science news

Minneapolis, Minnesota (October 29, 2018) - Society of Vascular and Interventional Neurology's 2018 annual meeting to showcase breakthrough technology on stroke thrombectomy offering a ray of hope for stroke patients worldwide. The results of latest clinical trials and breaking science news related to the use of vacuum aspiration for removing blood clots in stroke patients will be presented at the upcoming SVIN annual meeting in San Diego.